

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Natalizumab is a prescription medication given through IV infusion to treat multiple sclerosis and Crohn's disease. It works by blocking certain immune system cells from reaching your brain and intestines, which helps reduce inflammation and slow disease progression.
This medication belongs to a class called monoclonal antibodies, which are specially designed proteins that target specific parts of your immune system. Think of it as a targeted approach rather than a broad treatment that affects your whole body.
Natalizumab treats two main conditions where your immune system mistakenly attacks healthy tissue. Your doctor prescribes it when other treatments haven't worked well enough or when you need stronger intervention.
For multiple sclerosis, natalizumab helps prevent relapses and reduces the formation of new brain lesions. It's particularly effective for relapsing forms of MS, where symptoms come and go in episodes.
In Crohn's disease, this medication helps control severe inflammation in your intestines. Your gastroenterologist might recommend it when standard treatments like steroids or immunosuppressants haven't provided adequate relief.
The medication is typically reserved for moderate to severe cases because it's quite powerful. Your doctor will carefully evaluate whether the benefits outweigh the risks for your specific situation.
Natalizumab blocks a protein called alpha-4 integrin on immune cells, preventing them from crossing into your brain or intestinal tissue. This creates a protective barrier that reduces inflammation where you need it most.
Your immune system normally uses these proteins like keys to unlock entry into different parts of your body. By blocking these "keys," natalizumab keeps inflammatory cells from reaching areas where they cause damage.
This is considered a strong medication because it significantly affects your immune system's ability to function normally. While this helps control your condition, it also requires careful monitoring for potential complications.
The effects build up over time, so you might not notice immediate improvement. Most people begin seeing benefits within the first few months of treatment.
Natalizumab is given as an intravenous infusion in a medical facility, typically once every four weeks. You'll receive the medication through a small tube placed in your arm vein over about one hour.
Before each infusion, you'll need blood tests to check your immune system and overall health. Your healthcare team will also monitor you for at least one hour after the infusion to watch for any immediate reactions.
You don't need to fast before treatment, but eating a light meal beforehand can help prevent nausea. Bring something to keep yourself occupied during the infusion, like a book or tablet.
Your medical team will premedicate you with antihistamines or steroids if you've had reactions before. This helps prevent infusion-related side effects like headaches or skin reactions.
Most people take natalizumab for at least one to two years to see meaningful benefits, though some continue longer depending on their response. Your doctor will regularly assess whether the medication is helping and if it's still the right choice for you.
The decision to continue depends on how well you're responding and your risk factors for complications. Your doctor will check your JC virus antibody status every six months, as this affects your risk profile.
Some people take scheduled breaks from treatment, called drug holidays, to reduce certain risks. Your doctor might recommend this approach if you've been on the medication for several years.
Never stop natalizumab suddenly without medical guidance. Your doctor will help you transition safely to another treatment if needed to prevent disease rebound.
Most people tolerate natalizumab well, but like all powerful medications, it can cause side effects ranging from mild to serious. Understanding what to expect helps you feel more prepared and know when to seek help.
Common side effects that many people experience include headaches, fatigue, and joint pain. These usually occur within the first few treatments and often improve as your body adjusts to the medication.
Here are the most frequently reported side effects:
These common effects are generally manageable and don't require stopping treatment. Your healthcare team can suggest ways to minimize discomfort.
More serious side effects require immediate medical attention, though they're less common. The most concerning is progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection.
Watch for these warning signs that need urgent evaluation:
Your medical team monitors you closely for these rare but serious complications. Regular brain MRIs help detect any concerning changes early.
Liver problems can also occur, though this is uncommon. Your doctor will check your liver function regularly through blood tests to catch any issues early.
Natalizumab isn't suitable for everyone, particularly those with certain infections or immune system conditions. Your doctor will carefully screen you before starting treatment to ensure it's safe.
You shouldn't take natalizumab if you have an active infection, especially those affecting your brain or nervous system. This includes conditions like meningitis or encephalitis.
People with compromised immune systems from other causes should avoid this medication. This includes those with HIV, organ transplants, or taking other strong immunosuppressive drugs.
Certain medical conditions make natalizumab too risky to use safely:
Your doctor will also consider your JC virus antibody status, as positive results increase your risk of complications. This doesn't automatically disqualify you, but it affects the risk-benefit calculation.
Age isn't necessarily a barrier, but older adults may need more careful monitoring. Your doctor will weigh all factors to determine if natalizumab is appropriate for your situation.
Natalizumab is available under the brand name Tysabri, which is the most commonly prescribed version. This is the original formulation that has been used for many years with extensive research backing its effectiveness.
A newer version called Tyruko (natalizumab-sztn) is also available, which is what's known as a biosimilar. Biosimilars are highly similar to the original medication but may be produced by different manufacturers.
Both versions work essentially the same way and have similar effectiveness. Your doctor or insurance plan might prefer one over the other based on availability or cost considerations.
The -sztn suffix in natalizumab-sztn is simply a way to distinguish this particular biosimilar version from the original. It doesn't indicate any difference in how the medication works.
Several other medications can treat multiple sclerosis and Crohn's disease if natalizumab isn't suitable for you. Your doctor will consider your specific condition, medical history, and treatment goals when exploring alternatives.
For multiple sclerosis, other disease-modifying therapies include interferon medications, glatiramer acetate, and newer oral options like fingolimod or dimethyl fumarate. Each has different benefits and side effect profiles.
Crohn's disease alternatives include other biologic medications like infliximab, adalimumab, or vedolizumab. These work through different mechanisms but can be equally effective for many people.
Some people do well with traditional immunosuppressants like methotrexate or azathioprine. These require different monitoring but may be appropriate depending on your situation.
The choice depends on factors like your disease severity, previous treatment response, and personal preferences about route of administration. Your doctor will help you weigh these options carefully.
Both natalizumab and ocrelizumab are effective treatments for multiple sclerosis, but they work differently and may be better suited for different people. The "better" choice depends on your specific situation and risk factors.
Natalizumab is given monthly and targets a specific pathway to prevent immune cells from entering the brain. Ocrelizumab is given every six months and works by depleting certain immune cells called B cells.
In terms of effectiveness, both medications significantly reduce relapse rates and slow disability progression. Some studies suggest natalizumab may be slightly more effective at preventing relapses, while ocrelizumab may be better at slowing disability progression.
The side effect profiles differ meaningfully between these medications. Natalizumab carries a risk of PML, while ocrelizumab may increase infection risk and has potential concerns about certain cancers.
Your doctor will consider factors like your JC virus status, infection history, and treatment preferences when choosing between these options. Both are excellent medications when used in the right person.
Is Natalizumab Safe for People with Diabetes?
Natalizumab can generally be used safely in people with diabetes, but your blood sugar control needs to be well-managed before starting treatment. Good diabetes management is important because natalizumab affects your immune system.
Your doctor will want to ensure your diabetes is stable and that you don't have complications like diabetic foot ulcers or frequent infections. These conditions could worsen if your immune system is further suppressed.
Regular monitoring becomes even more important when you have both conditions. Your healthcare team will coordinate between your neurologist or gastroenterologist and your diabetes specialist.
What Should I Do if I Accidentally Receive Too Much Natalizumab?
Overdose with natalizumab is unlikely since it's given by healthcare professionals in controlled medical settings. However, if you receive a higher dose than prescribed, inform your medical team immediately.
There's no specific antidote for natalizumab overdose, so treatment focuses on monitoring and managing any symptoms that develop. Your healthcare team will watch you closely for increased side effects.
Most overdose situations involve receiving the medication too frequently rather than too much at once. Your doctor will adjust your schedule and monitoring if this happens.
What Should I Do if I Miss a Dose of Natalizumab?
If you miss your scheduled natalizumab infusion, contact your healthcare provider as soon as possible to reschedule. The timing of your next dose depends on how long it's been since your last treatment.
Missing one dose occasionally isn't usually dangerous, but consistency is important for maintaining the medication's effectiveness. Your doctor might recommend returning to your regular schedule or adjusting the timing.
Don't try to "catch up" by receiving doses closer together than recommended. This could increase your risk of side effects without providing additional benefits.
When Can I Stop Taking Natalizumab?
The decision to stop natalizumab should always be made with your doctor's guidance, considering factors like your disease activity, treatment response, and risk factors. Most people continue treatment for at least one to two years.
Your doctor might recommend stopping if you develop concerning side effects, if the medication stops working effectively, or if your risk of complications becomes too high. This is particularly relevant for people who develop high JC virus antibody levels.
When stopping natalizumab, your doctor will typically transition you to another treatment to prevent disease rebound. This transition needs to be carefully planned and monitored.
Can I Get Vaccinations While Taking Natalizumab?
You can receive most vaccines while taking natalizumab, but live vaccines should be avoided because they could cause infections in people with suppressed immune systems. Your doctor will review your vaccination needs regularly.
Inactivated vaccines like the flu shot, pneumonia vaccine, and COVID-19 vaccines are generally safe and recommended. However, they might not work as well while you're on natalizumab.
Plan to update your vaccinations before starting natalizumab if possible. Your doctor will provide specific guidance based on your individual situation and current vaccination status.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.